For many men, the bathroom routine is a private, unspoken metric of aging. It starts with a slight delay at the urinal, then a few extra trips during the night, and eventually, a persistent feeling that the bladder never quite empties. Most men rationalize these changes as an inevitable tax on getting older. Urologists at Shanghai Yueyang Hospital, however, see a different reality: these are often the first signals of prostate disease, a condition that thrives on being ignored.

Prostate cancer remains one of the most common malignancies in men globally. Because early-stage disease is notoriously quiet, the symptoms that finally drive men to a clinic often appear only after the cancer has progressed. Understanding the difference between benign changes and genuine red flags is the difference between a manageable health issue and a life-altering diagnosis.

Who Needs to Prioritize Screening

Waiting for symptoms to appear is a losing strategy. According to clinical guidelines, five specific groups of men should be proactive about screening rather than waiting for a physical trigger:

  • Men over 50: The risk curve shifts upward significantly with age. By age 70, the statistical risk is exponentially higher than at 50.
  • Family history: If a father or brother had prostate cancer, your risk is two to three times the baseline. If multiple family members were affected, or if a diagnosis occurred before age 60, screening should begin at 45.
  • Genetic carriers: Men with BRCA2 mutations—often associated with breast cancer—face a higher risk of aggressive prostate cancer and should begin annual screening at age 40.
  • Lifestyle factors: High-fat diets, central obesity, heavy smoking, and chronic alcohol consumption are all linked to elevated risk profiles.
  • Existing BPH: Men already diagnosed with benign prostatic hyperplasia (BPH) require regular monitoring, as BPH and cancer can coexist, and symptoms alone cannot distinguish between the two.

The PSA Misconception

Prostate-specific antigen (PSA) is a protein produced by the prostate gland. While it is the standard blood test for screening, it is frequently misunderstood. A high PSA level is not a cancer diagnosis; it is a signal that the prostate is under stress or undergoing change.

Many factors can cause a spike in PSA that have nothing to do with malignancy. Prostatitis (inflammation), BPH, recent strenuous exercise like cycling, or even a recent digital rectal exam can skew results. Because of this, a single high reading is rarely the end of the story. Physicians typically follow up with further testing or repeat the blood work after a period of rest to clear out potential "noise" from the initial test.

What Experts Say

"The biggest hurdle we face is the 'silent' nature of early-stage prostate cancer," says Dr. Peng Yu of the department of urological surgery at Shanghai Yueyang Hospital. "Men often wait until they experience pain or significant urinary obstruction, but by then, we have lost the window for the most effective, least invasive interventions. Screening is not about finding a reason to worry; it is about establishing a baseline so that when change happens, we catch it early."

Medical experts emphasize that while the prospect of a diagnosis is daunting, the integration of modern diagnostic tools and personalized treatment plans—including both Western surgical techniques and traditional supportive care—has significantly improved outcomes for those who seek help early.

Key Takeaways

  • Don't normalize symptoms: Frequent nighttime urination, weak flow, and urinary hesitation are not just "getting older"—they are medical signals.
  • Know your risk: If you have a family history or specific genetic markers, you should start screening years before the general population.
  • PSA is a starting point, not a verdict: A high PSA score requires clinical investigation, not immediate panic, as many non-cancerous factors can influence the result.

This article is for informational purposes only. Always consult a qualified healthcare professional before making any medical decisions.